Frederick M. Hudson - 23 Feb 2023 Form 4 Insider Report for SUPERNUS PHARMACEUTICALS, INC. (SUPN)

Role
Director
Signature
/s/ Timothy C. Dec, as attorney-in-fact
Issuer symbol
SUPN
Transactions as of
23 Feb 2023
Transactions value $
$0
Form type
4
Filing time
27 Feb 2023, 16:02:29 UTC
Previous filing
24 Feb 2023
Next filing
08 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding SUPN Common Stock 34.9K 23 Feb 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SUPN Director Stock Option (Right to Buy) Award $0 +6.29K $0.00 6.29K 23 Feb 2023 Common Stock 6.29K $38.60 Direct F1
transaction SUPN Restricted Stock Units Award $0 +3.89K $0.00 3.89K 23 Feb 2023 Common Stock 3.89K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests on February 23, 2024.
F2 Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting.
F3 These restricted stock units will be settled in common stock upon vesting, which will occur on February 23, 2024.